Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SRF617 |
Trade Name | |
Synonyms | SRF-617|SRF 617 |
Drug Descriptions |
SRF617 is a monoclonal antibody that binds to CD39 and inhibits the conversion of ATP to AMP, potentially resulting in enhanced adaptive and innate immune response against tumor cells (NCI Thesaurus). |
DrugClasses | CD39 Antibody 5 |
CAS Registry Number | NA |
NCIT ID | C171450 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Etrumadenant + SRF617 + Zimberelimab | Etrumadenant SRF617 Zimberelimab | 0 | 1 |
SRF617 | SRF617 | 0 | 1 |